Skip to main content

Table 6 Comparison of epidemiologic cutoff values (ECV) of A. flavus with Etest MICs obtained in the present study by Etest

From: Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait

Drug ECV (μg/μl)* % of isolates ≤ ECV  
   RPMI 1640 MH-GMB
Voriconazole 1.0 (98.1%) 92 (100 %) 92 (100 %)
Posaconazole 0.25 (95 %) 91 (98.9 %) 86 (93.5 %)
Caspofungin 0.25 (95%) 92 (100 %) 92 (100%)
Amphotericin B 4.00 (99%) 92 (100%) 89 (96.7%)
  1. *Espinel-Ingroff et al. [1416].
  2. Note: Epidemiologic cutoff of wild-type strains of A. flavus are not available for micafungin and anidulafungin.